Quest Diagnostics Incorporated (DGX)

NYSE: DGX · Real-Time Price · USD
174.34
+0.69 (0.40%)
Jun 6, 2025, 4:00 PM - Market closed
0.40%
Market Cap 19.46B
Revenue (ttm) 10.16B
Net Income (ttm) 892.00M
Shares Out 111.64M
EPS (ttm) 7.91
PE Ratio 22.05
Forward PE 17.65
Dividend $3.20 (1.84%)
Ex-Dividend Date Jul 7, 2025
Volume 434,248
Open 174.21
Previous Close 173.65
Day's Range 174.17 - 175.50
52-Week Range 135.47 - 179.99
Beta 0.49
Analysts Buy
Price Target 185.07 (+6.16%)
Earnings Date Jul 22, 2025

About DGX

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,... [Read more]

Sector Healthcare
IPO Date Dec 17, 1996
Employees 56,000
Stock Exchange NYSE
Ticker Symbol DGX
Full Company Profile

Financial Performance

In 2024, Quest Diagnostics's revenue was $9.87 billion, an increase of 6.70% compared to the previous year's $9.25 billion. Earnings were $866.00 million, an increase of 1.88%.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for DGX stock is "Buy." The 12-month stock price forecast is $185.07, which is an increase of 6.16% from the latest price.

Price Target
$185.07
(6.16% upside)
Analyst Consensus: Buy
Stock Forecasts

News

More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals

Quest's second "Know Your Health" survey explores Americans' perceptions and priorities on their well-being in 2025 Nearly one-third of Americans say their doctors/HCPs do not take the time to discuss...

18 days ago - PRNewsWire

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

SECAUCUS, N.J. , May 16, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak...

21 days ago - PRNewsWire

Quest Diagnostics Declares Quarterly Cash Dividend

SECAUCUS, N.J. , May 14, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend...

23 days ago - PRNewsWire

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds

More than 3 in 4 oncologists (76%) feel they are seeing more advanced cancers, and of these, 75% believe that screening barriers are the leading cause, although nearly one-third (32%) cite "factors th...

25 days ago - PRNewsWire

Quest Diagnostics: A Leader But Waiting For Better Price

Quest Diagnostics excels in scale, scope, and service quality, leveraging automation and distribution to reduce costs and offer comprehensive test menus. Despite its strengths, I recommend waiting to ...

5 weeks ago - Seeking Alpha

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings

Quest Diagnostics Incorporated DGX posted better-than-expected first-quarter earnings on Tuesday.

6 weeks ago - Benzinga

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

Quest Diagnostics Inc DGX reported on Tuesday that first-quarter 2025 sales of $2.65 billion, up 12.1% year over year, beat the consensus of $2.63 billion.

6 weeks ago - Benzinga

Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript

Quest Diagnostics Incorporated (NYSE:DGX) Q1 2025 Results Conference Call April 22, 2025 8:30 AM ET Company Participants Shawn Bevec - Vice President of Investor Relations Jim Davis - Chairman, Chief...

6 weeks ago - Seeking Alpha

Quest beats quarterly profit estimates on strong demand for diagnostic tests

Laboratory operator Quest Diagnostics beat Wall Street estimates for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests.

6 weeks ago - Reuters

Quest Diagnostics earnings beat after March rebound in demand from slump early in the quarter

Quest Diagnostics Inc.'s stock fell 3.6% early Tuesday, after the company posted better-than-expected first-quarter earnings and backed its guidance, but said the early part of the quarter was slow.

6 weeks ago - Market Watch

Quest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025

First quarter revenues of $2.65 billion, up 12.1% from 2024 First quarter reported diluted earnings per share ("EPS") of $1.94, up 12.8% from 2024; and adjusted diluted EPS of $2.21, up 8.3% from 2024...

6 weeks ago - PRNewsWire

Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease

In an oral presentation at the 2025 AAN Annual Meeting, Quest scientists presented data suggesting the test can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and sp...

2 months ago - PRNewsWire

8 Upcoming Dividend Increases During Volatile Times

8 Upcoming Dividend Increases During Volatile Times

Other symbols: AMTBKUGDKAIORCLREITRNP
2 months ago - Seeking Alpha

Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

Providers in the United States may now order the FDA-cleared HPV self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to scree...

2 months ago - PRNewsWire

Quest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025

SECAUCUS, N.J. , April 1, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2025 financial resul...

2 months ago - PRNewsWire

Quest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day

Provides long-term outlook beyond 2025: Revenues expected to grow at 4-5% compound annual growth rate (CAGR); adjusted diluted earnings per share (EPS) expected to grow at 7-9% CAGR Reaffirms guidance...

2 months ago - PRNewsWire

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

Quest to provide comprehensive dialysis-related laboratory and water testing services to Fresenius Medical Care owned and affiliated clinics in the United States BAD HOMBURG, Germany and SECAUCUS, N.J...

Other symbols: FMS
3 months ago - PRNewsWire

Quest Diagnostics to Host Investor Day on March 19, 2025

SECAUCUS, N.J. , Feb. 13, 2025 /PRNewswire/ --  Quest Diagnostics  (NYSE: DGX), a leading provider of diagnostic information services, will host an Investor Day for institutional investors and financi...

4 months ago - PRNewsWire

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

GRAIL's Galleri   Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience  MENLO PARK, Calif. ...

Other symbols: GRAL
4 months ago - PRNewsWire

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

SECAUCUS, N.J. , Jan. 30, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been selected as one of the 2025 World'...

4 months ago - PRNewsWire

Quest Diagnostics Incorporated (DGX) Q4 2024 Earnings Call Transcript

Quest Diagnostics Incorporated (NYSE:DGX) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Jim Davis - President & CEO Sam Samad - EVP & CFO Shawn Bevec - VP, IR Conf...

4 months ago - Seeking Alpha

Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share

Fourth quarter revenues of $2.62 billion, up 14.5% from 2023 Fourth quarter reported diluted earnings per share ("EPS") of $1.95, up 14.7% from 2023; and adjusted diluted EPS of $2.23, up 3.7% from 20...

4 months ago - PRNewsWire

Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals

Physicians and patients to benefit from access to Quest's industry-leading test menu and broad health plan relationships in Ohio SECAUCUS, N.J. and CLEVELAND , Jan. 27, 2025 /PRNewswire/ -- Quest Diag...

4 months ago - PRNewsWire

Quest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer

Quality and regulatory veteran of Getinge, BD and J&J joins the Quest Diagnostics executive team SECAUCUS, N.J. , Jan. 8, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diag...

5 months ago - PRNewsWire